Lupron and prostate cancer 
Lupron and prostate cancer Patient Reports February 12, 2012
Lupron Side Effects Report #5807036-4
Lupron side effect was reported by a Consumer or non-health professional from JAPAN on July 01, 2008. Male patient, 89 years of age, was diagnosed with prostate cancer stage iv, hypovitaminosis, benign prostatic hyperplasia, musculoskeletal pain, oedema, gastritis and was treated with Lupron. After drug was administered, patient experienced the following side effects: anaemia, bronchitis chronic, gastritis, prostate cancer
. Lupron dosage: unknown. During the same period patient was treated with ALINAMIN, BICALUTAMIDE, TAMSULOSIN, PREDNISONE, TORSEMIDE, TEPRENONE. Patient died on 04/11/2008.Lupron Side Effects Report #5873342-0
Lupron side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2008. Male patient, 89 years of age, was diagnosed with prostate cancer stage iv, hypovitaminosis, benign prostatic hyperplasia, musculoskeletal pain, oedema, gastritis and was treated with Lupron. After drug was administered, patient experienced the following side effects: anaemia, bronchitis chronic, gastritis, prostate cancer
. Lupron dosage: unknown. During the same period patient was treated with ALINAMIN, BICALUTAMIDE, TAMSULOSIN, PREDNISONE, TORSEMIDE, TEPRENONE. Patient died on 04/11/2008.Lupron Side Effects Report #4989790-7
Lupron side effect was reported by a Health Professional from CANADA on Apr 21, 2006. Male patient, 86 years of age, was diagnosed with prostate cancer
and was treated with Lupron. After drug was administered, patient experienced the following side effects: coma, malignant neoplasm progression, metastases to bone, metastases to lung, prostate cancer . Lupron dosage: 30 MG, 1 IN 4 M, INTRAMUSCULAR. During the same period patient was treated with ADALAT, NOVASEN, ATIVAN, GEN LOVASTATIN, VASOTEC, APO K, FERROUS SULPHATE, APO LISINOPRIL. Patient died on 12/20/2005.Lupron Side Effects Report #5243275-1
Lupron side effect was reported by a Consumer or non-health professional from CANADA on Feb 08, 2007. Male patient, 85 years of age, was diagnosed with prostate cancer
and was treated with Lupron. After drug was administered, patient experienced the following side effects: cardiac disorder, condition aggravated, metastases to bone, prostate cancer , renal disorder. Lupron dosage: 30 MG, 1 IN 4 M, INTRAMUSCULAR. During the same period patient was treated with GLYBURIDE, COREG, PRILOSEC, ASPIRIN, WARFARIN, CRESTOR, CASODEX, FLOMAX. Patient was hospitalized. Patient died on 01/24/2007.Lupron Side Effects Report #5361356-9
Lupron side effect was reported by a Consumer or non-health professional from CANADA on June 08, 2007. Male patient, 85 years of age, was diagnosed with prostate cancer
and was treated with Lupron. After drug was administered, patient experienced the following side effects: cardiac disorder, malignant neoplasm progression, metastases to bone, prostate cancer , renal disorder. Lupron dosage: 30 MG, 1 IN 4 M, INTRAMUSCULAR. During the same period patient was treated with GLYBURIDE, COREG, PRILOSEC, ASPIRIN, WARFARIN, CRESTOR, CASODEX, FLOMAX. Patient was hospitalized. Patient died on 01/24/2007.Lupron Side Effects Report #5305712-3
Lupron side effect was reported by a Consumer or non-health professional from CANADA on Apr 02, 2007. Male patient, 84 years of age, was diagnosed with prostate cancer
and was treated with Lupron. After drug was administered, patient experienced the following side effects: ankle fracture, anorexia, bone neoplasm malignant, fall , malignant neoplasm progression, prostate cancer . Lupron dosage: 30 MG, 1 IN 4 M, INTRAMUSCULAR. During the same period patient was treated with NOVASEN, LESCOL, ARTHROTEC, COMBIVENT. Patient was hospitalized. Patient died on 09/10/2006.Lupron Side Effects Report #5011144-8
Lupron side effect was reported by a Pharmacist from CANADA on May 11, 2006. Male patient, 81 years of age, was diagnosed with prostate cancer
and was treated with Lupron. After drug was administered, patient experienced the following side effects: prostate cancer . Lupron dosage: 22.5 MG, 1 IN 1 M, INTRAMUSCULAR. During the same period patient was treated with FUROSEMIDE, DILAUDID, PANTOLOC, SOTALOL, DURAGESIC, NITRO PATCH, MACROBID, GRAVOL. Patient died on 04/24/2006.Lupron Side Effects Report #4951230-1
Lupron side effect was reported by a Pharmacist from CANADA on Mar 13, 2006. Male patient, 79 years of age, was diagnosed with prostate cancer
and was treated with Lupron. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, prostate cancer . Lupron dosage: 22.5 MG, 1 IN 3 M, INTRAMUSCULAR. During the same period patient was treated with PREDNISONE. Patient died on 02/09/2006.Lupron Side Effects Report #5136495-8
Lupron side effect was reported by a Health Professional from CANADA on Oct 13, 2006. Male patient, 77 years of age, was diagnosed with prostate cancer
and was treated with Lupron. After drug was administered, patient experienced the following side effects: arthralgia, cerebral atrophy, confusional state, gastrointestinal carcinoma, hepatic neoplasm malignant, prostate cancer . Lupron dosage: 22.5 MG, 1 IN 3 M. During the same period patient was treated with CALCIUM, VITAMIN D, ESLON, VASOTEC, LABETALON, ALLOPURINOL, RANITIDINE, SIMVASTATIN. Patient was hospitalized. Patient died on 10/04/2006.Lupron Side Effects Report #4909274-1
Lupron side effect was reported by a Physician from UNITED STATES on Feb 08, 2006. Male patient, 77 years of age, weighting 158.0 lb, was diagnosed with prostate cancer
and was treated with Lupron. After drug was administered, patient experienced the following side effects: prostate cancer . Lupron dosage: 30 MG Q 3 MONTHS. Patient recovered.Lupron Side Effects Report #5248072-9
Lupron side effect was reported by a Consumer or non-health professional from CANADA on Feb 14, 2007. Male patient, 67 years of age, was diagnosed with prostate cancer
and was treated with Lupron. After drug was administered, patient experienced the following side effects: asthenia, computerised tomogram abnormal, disorientation, metastases to bone, metastases to liver, prostate cancer , prostatic specific antigen increased, stomatitis. Lupron dosage: 22.5 MG, 1 IN 3 M, INTRAMUSCULAR. During the same period patient was treated with DILAUDID, FENTANYL. Patient was hospitalized. Patient died on 02/01/2007.Lupron Side Effects Report #5261413-1
Lupron side effect was reported by a Consumer or non-health professional from CANADA on Mar 01, 2007. Male patient, 67 years of age, was diagnosed with prostate cancer
and was treated with Lupron. After drug was administered, patient experienced the following side effects: asthenia, cerebral disorder, disorientation, malignant neoplasm progression, metastases to bone, metastases to liver, prostate cancer , stomatitis. Lupron dosage: 22.5 MG, 1 IN 3 M, INTRAMUSCULAR. During the same period patient was treated with DILAUDID, FENTANYL. Patient was hospitalized. Patient died on 02/01/2007.Lupron Side Effects Report #5798611-4
Lupron side effect was reported by a Consumer or non-health professional from BELGIUM on June 25, 2008. Male patient, weighting 165.3 lb, was diagnosed with prostate cancer
and was treated with Lupron. After drug was administered, patient experienced the following side effects: atrial fibrillation , prostate cancer . Lupron dosage: unknown. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient died on 11/09/2007.Lupron Side Effects Report #6037553-6
Lupron side effect was reported by a Consumer or non-health professional from CANADA on Jan 09, 2009. Male patient, weighting 190.2 lb, was diagnosed with prostate cancer
and was treated with Lupron. After drug was administered, patient experienced the following side effects: metastases to bone, prostate cancer . Lupron dosage: unknown. During the same period patient was treated with DILANTIN, PRIMODONE, VITAMIN D, CALCIUM. Patient was hospitalized. Patient died on 11/24/2008.Lupron Side Effects Report #6045462-1
Lupron side effect was reported by a Consumer or non-health professional from CANADA on Jan 13, 2009. Male patient, weighting 175.2 lb, was diagnosed with prostate cancer
, international normalised ratio, depression and was treated with Lupron. After drug was administered, patient experienced the following side effects: prostate cancer , renal failure. Lupron dosage: unknown. During the same period patient was treated with WARFARIN, CITALOPRAM HYDROBROMIDE, FLOMAX, ARTHROTEC. Patient died on 01/03/2009.